Pharmacists in East Palo Alto, CA Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Minh Nguyen Dang Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 E Bayshore Rd, East Palo Alto, CA 94303 Phone: 650-325-2018 |
 Arthur Herbert Lim, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2111 University Ave, East Palo Alto, CA 94303 Phone: 650-321-1449 Fax: 650-321-5977 |
Varsha S Gadgil Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1885 Bay Rd Ste A, East Palo Alto, CA 94303 Phone: 650-330-7457 |
Soo Ah Kwon Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 E Bayshore Rd, East Palo Alto, CA 94303 Phone: 650-325-2018 |
Kristy Mai Nishikawa, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1885 Bay Rd, East Palo Alto, CA 94303 Phone: 650-617-7834 |
News Archive
Tyrosine kinases could act as drivers for growth and survival of sarcomas
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.
Novartis presents 2010 Immunology prizes at 16th International Congress of Immunology in Kobe
The Novartis 2010 Immunology Prizes were presented at the 16th International Congress of Immunology in Kobe, Japan. Since 1992, the Novartis Prizes for Immunology have been awarded every third year for outstanding contributions to basic and clinical immunology. The prizes recognize individual achievement and provide financial support for further research by the recipients. The prizes are a major feature of the triennial International Congress of Immunology.
NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for celiac disease
Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), to support the development of a novel antibody therapeutic for celiac disease.
UCLA pediatrician receives 2012 Nemours Child Health Services Research Award
Dr. Tumaini Rucker Coker, assistant professor of pediatrics at the David Geffen School of Medicine at UCLA and Mattel Children's Hospital UCLA was honored with the 2012 Nemours Child Health Services Research Award at the Academy Health annual research meeting in Orlando on June 23.
Dendreon provides U.S. commercialization and European strategy updates for PROVENGE
Dendreon Corporation today announced several updates regarding the U.S. commercialization of PROVENGE® (sipuleucel-T), the European strategy for PROVENGE, and progress on its pipeline.
› Verified 7 days ago
Counselors
Marriage Counselors
Pharmacists
Clinical Social Workers
Psychologists
Dentists